Capital International Investors Novartis Ag Transaction History

Capital International Investors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $60.9 Million - $73.7 Million	-780,185 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $2.7 Million - $2.99 Million	32,839 Added 4.39%	780,185 $67.9 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $32.3 Million - $36.4 Million	-399,590 Reduced 34.84%	747,346 $65.3 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $49.6 Million - $69.4 Million	701,358 Added 157.4%	1,146,936 $94.6 Million
Q4 2019 Feb 18, 2020	BUY	$84.35 - $95.37 $40,234 - $45,491	477 Added 0.11%	445,578 $42.2 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $29.7 Million - $32.7 Million	-346,945 Reduced 43.8%	445,101 $38.7 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $54,665 - $67,280	725 Added 0.09%	792,046 $72.3 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $50.7 Million - $58 Million	-672,749 Reduced 45.95%	791,321 $76.1 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $73 - $82	1 Added 0.0%	1,464,070 $126 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $133 - $154	2 Added 0.0%	1,464,069 $126 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $4,348 - $4,915	67 Added 0.0%	1,464,067 $111 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $109 Million - $113 Million	1,464,000	1,464,000 $126 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.